BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almanzar G, Kienle F, Schmalzing M, Maas A, Tony HP, Prelog M. Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis. Rheumatology (Oxford) 2019;58:2051-60. [PMID: 31106368 DOI: 10.1093/rheumatology/kez175] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Kao CM, Hsieh TY, Lai KL. The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib. Arch Rheumatol 2021;36:305-7. [PMID: 34527938 DOI: 10.46497/ArchRheumatol.2021.8212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu S, Yang S, Ou M, Chen J, Huang J, Xiong D, Sun W, Xiao L. Transcriptome Analysis Reveals the Role of Cellular Calcium Disorder in Varicella Zoster Virus-Induced Post-Herpetic Neuralgia. Front Mol Neurosci 2021;14:665931. [PMID: 34079439 DOI: 10.3389/fnmol.2021.665931] [Reference Citation Analysis]
3 Iglesias M, Khalifian S, Oh BC, Zhang Y, Miller D, Beck S, Brandacher G, Raimondi G. A short course of tofacitinib sustains the immunoregulatory effect of CTLA4-Ig in the presence of inflammatory cytokines and promotes long-term survival of murine cardiac allografts. Am J Transplant 2021;21:2675-87. [PMID: 33331121 DOI: 10.1111/ajt.16456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Seitel T, Cagol L, Prelog M, Frivolt K, Krahl A, Trenkel S, Speth F, Mayer B, Almanzar G, Koletzko S, Debatin KM, Mertens T, Posovszky C. Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study. Vaccine 2020;38:8024-31. [PMID: 33160754 DOI: 10.1016/j.vaccine.2020.10.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hosomi S, Nishida Y, Fujiwara Y. The Impact of Human Herpesviruses in Clinical Practice of Inflammatory Bowel Disease in the Era of COVID-19. Microorganisms 2021;9:1870. [PMID: 34576764 DOI: 10.3390/microorganisms9091870] [Reference Citation Analysis]
6 Texler B, Zollner A, Reinstadler V, Reider SJ, Macheiner S, Jelusic B, Pfister A, Watschinger C, Przysiecki N, Tilg H, Oberacher H, Moschen AR. Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00192-2. [PMID: 34624526 DOI: 10.1016/j.jcmgh.2021.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Garufi C, Maclean M, Gadina M, Spinelli FR. Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis. Expert Rev Clin Immunol 2022. [PMID: 35168456 DOI: 10.1080/1744666X.2022.2042254] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lee KH, Choi S, Kwon JS, Kim SH, Park SY. Varicella zoster virus (VZV)-specific immunity and subclinical VZV reactivation in patients with autoimmune diseases. Korean J Intern Med 2021;36:992-1000. [PMID: 34126665 DOI: 10.3904/kjim.2020.672] [Reference Citation Analysis]
9 Novais FO, Nguyen BT, Scott P. Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis. J Invest Dermatol 2021;141:575-85. [PMID: 32738245 DOI: 10.1016/j.jid.2020.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Dagnew AF, Rausch D, Hervé C, Zahaf T, Levin MJ, Schuind A; ZOE-50/70 study group. Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials. Rheumatology (Oxford) 2021;60:1226-33. [PMID: 32910152 DOI: 10.1093/rheumatology/keaa424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Zhang Y, Wang S, Song S, Yang X, Jin G. Ginsenoside Rg3 Alleviates Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Mice by Regulating CD4+CD25+Foxp3+Treg Cells. J Agric Food Chem 2020;68:4893-902. [PMID: 32275817 DOI: 10.1021/acs.jafc.0c01473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Solimani F, Meier K, Ghoreschi K. Emerging Topical and Systemic JAK Inhibitors in Dermatology. Front Immunol 2019;10:2847. [PMID: 31849996 DOI: 10.3389/fimmu.2019.02847] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 17.3] [Reference Citation Analysis]